TAM
FOLD

Tiverton Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Tiverton Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$50K Buy
+6,177
New +$67K ﹤0.01% 691

Other funds holding FOLD

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Tiverton Asset Management's FOLD Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in Amicus Therapeutics (FOLD) in Q3 2019: 6,177 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #691 among its holdings.

205 funds tracked by Wall St. Rank hold FOLD as of Q3 2019.

  • Tiverton Asset Management held 6,177 shares of Amicus Therapeutics worth $50K as of Q3 2019.
  • Amicus Therapeutics was a new Tiverton Asset Management position in Q3 2019.
  • Amicus Therapeutics made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #691 holding.
  • 205 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.